A phase I and pharmacokinetic (PK) study of the novel mushroom-derived cytotoxin, MGI114, in patients with advanced cancer

被引：0
|
作者：
Eckhardt, SG
Baker, SD
Moczygemba, J
MacDonald, JR
Smith, S
Von Hoff, DD
Rowinsky, EK
机构：
[1] Canc Therapy & Res Ctr, San Antonio, TX 78229 USA
[2] MGI Pharma, Minnetonka, MN USA
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
471
引用
收藏
页码：123 / 123
页数：1
相关论文
共 50 条
  • [41] Phase I and pharmacokinetic study of kahalalide F in patients with advanced androgen refractory prostate cancer
    Rademaker-Lakhai, JM
    Horenblas, S
    Meinhardt, W
    Stokvis, E
    De Reijke, TM
    Jimeno, JM
    Lazaro, LL
    Martin, JAL
    Beijnen, JH
    Schellens, JHM
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 (04) : 469 - 469
  • [42] Pharmacokinetic study of the novel platinum agent ZD0473 in combination with gemcitabine: A phase I study in patients with advanced cancer.
    O'Dwyer, PJ
    Stevenson, JP
    Redlinger, M
    Sun, W
    Giantonio, B
    Hahn, S
    Algazy, K
    Burnite, M
    Garcia-Vargas, J
    Roberts, DW
    Oliver, R
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3750S - 3750S
  • [43] Phase I and pharmacokinetic study of etoposide phosphate by protracted venous infusion in patients with advanced cancer
    Soni, N
    Meropol, NJ
    Pendyala, L
    Noel, D
    Schacter, LP
    Gunton, KE
    Creaven, PJ
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) : 766 - 772
  • [44] Phase I pharmacokinetic study of single agent trametinib in patients with advanced cancer and hepatic dysfunction
    Pei Jye Voon
    Eric X. Chen
    Helen X. Chen
    Albert C. Lockhart
    Solmaz Sahebjam
    Karen Kelly
    Ulka N. Vaishampayan
    Vivek Subbiah
    Albiruni R. Razak
    Daniel J. Renouf
    Sebastien J. Hotte
    Arti Singh
    Philippe L. Bedard
    Aaron R. Hansen
    S. Percy Ivy
    Lisa Wang
    Lee-Anne Stayner
    Lillian L. Siu
    Anna Spreafico
    Journal of Experimental & Clinical Cancer Research, 41
  • [45] A phase I pharmacokinetic study of ONT-093 in combination with paclitaxel in patients with advanced cancer
    Chi, KN
    Chia, SK
    Sikic, B
    Dixon, R
    Newman, M
    Wacher, VJ
    Toyonaga, B
    Hoth, D
    Gelmon, KA
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S156 - S156
  • [46] Pharmacokinetic(PK) and pharmacodynamic(PD) results of a phase I study of PD-0325901, a second generation oral MEK inhibitor, in patients with advanced cancer
    Tan, Weiwei
    DePrimo, Samuel
    Krishnamurthi, Smitha S.
    Rinehart, John J.
    Nabell, Lisle M.
    Nickens, Dana
    Bentivegna, Steven
    Wilner, Keith D.
    Ricart, Alejandro D.
    LoRusso, Patricia M.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3468S - 3468S
  • [47] A phase I dose escalation, pharmacokinetic (PK) and pharmacodynamic (PD) study of ES-285, a novel marine anti-cancer agent, in patients with advanced solid tumours.
    Baird, RD
    Planting, AS
    Reid, AH
    Kitzen, J
    Reade, S
    Escolar, L
    de las Heras, B
    Fong, P
    Molife, R
    Shaw, H
    Eskens, F
    de Bono, JS
    Verweij, J
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9055S - 9056S
  • [48] Phase I and Pharmacokinetic (PK) Study of Pazopanib in Combination with Two Schedules of Docetaxel (D) in Patients (pts) with Advanced Solid Tumors
    Hamberg, P.
    Mathijssen, R. H.
    de Bruijn, P.
    van der Biessen, D.
    Loos, W. J.
    Sleijfer, S.
    Verweij, J.
    de Jonge, M. J.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 177 - 177
  • [49] A phase I pharmacokinetic (PK) study of MBP-426, a novel liposome encapsulated oxaliplatin
    Sankhala, K. K.
    Mita, A. C.
    Adinin, R.
    Wood, L.
    Beeram, M.
    Bullock, S.
    Yamagata, N.
    Matsuno, K.
    Fujisawa, T.
    Phan, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [50] Phase I and pharmacokinetic (PK) study of pazopanib (P) in combination with two schedules of ifosfamide (I) in patients (pts) with advanced solid tumors (STs).
    Hamberg, Paul
    Boers-Sonderen, Marye
    Loos, Walter J.
    De Jonge, Maja J.
    Van der Graaf, Winette T. A.
    Suttle, Ben B.
    Eskens, Ferry
    Verweij, Jaap
    Van Herpen, Carla
    Sleijfer, Stefan
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345